BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 3094572)

  • 1. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
    Roncari G; Ziegler WH; Guentert TW
    Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).
    Klotz U; Kanto J
    Clin Pharmacokinet; 1988 Jan; 14(1):1-12. PubMed ID: 3127102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions and clinical pharmacokinetics of flumazenil.
    Klotz U
    Eur J Anaesthesiol Suppl; 1988; 2():103-8. PubMed ID: 2842128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flumazenil disposition and elimination in cirrhosis.
    Janssen U; Walker S; Maier K; von Gaisberg U; Klotz U
    Clin Pharmacol Ther; 1989 Sep; 46(3):317-23. PubMed ID: 2505960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of midazolam in man.
    Heizmann P; Eckert M; Ziegler WH
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):43S-49S. PubMed ID: 6138080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flumazenil kinetics in the elderly.
    Roncari G; Timm U; Zell M; Zumbrunnen R; Weber W
    Eur J Clin Pharmacol; 1993; 45(6):585-7. PubMed ID: 8157048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15-1788.
    Klotz U; Duka T; Dorow R; Doenicke A
    Br J Clin Pharmacol; 1985 Jan; 19(1):95-8. PubMed ID: 3919752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ro 15-1788 antagonizes the effects of diazepam in man without affecting its bioavailability.
    O'Boyle C; Lambe R; Darragh A; Taffe W; Brick I; Kenny M
    Br J Anaesth; 1983 Apr; 55(4):349-56. PubMed ID: 6404290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU; Vollmer KO
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and pharmacokinetics of flumazenil in the rat.
    Mandema JW; Gubbens-Stibbe JM; Danhof M
    Psychopharmacology (Berl); 1991; 103(3):384-7. PubMed ID: 2057540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Pharmacodynamics of procyclidine in man.
    Whiteman PD; Fowle AS; Hamilton MJ; Peck AW; Bye A; Dean K; Webster A
    Eur J Clin Pharmacol; 1985; 28(1):73-8. PubMed ID: 3987788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil: a benzodiazepine antagonist.
    Karavokiros KA; Tsipis GB
    DICP; 1990 Oct; 24(10):976-81. PubMed ID: 2244412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?
    Klotz U; Ziegler G; Rosenkranz B; Mikus G
    Br J Clin Pharmacol; 1986 Nov; 22(5):513-20. PubMed ID: 3098270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans.
    Bareggi SR; Truci G; Leva S; Zecca L; Pirola R; Smirne S
    Eur J Clin Pharmacol; 1988; 34(1):109-12. PubMed ID: 2896126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
    Jochemsen R; Wesselman JG; Hermans J; van Boxtel CJ; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):285S-290S. PubMed ID: 6661374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Willems B; Butterworth RF
    Hepatology; 1989 Dec; 10(6):969-72. PubMed ID: 2511137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a single intravenous and oral dose of pafenolol--a beta 1-adrenoceptor antagonist with atypical absorption and disposition properties--in man.
    Regårdh CG; Lundborg P; Gabrielsson M; Heggelund A; Kylberg-Hanssen K
    Pharm Res; 1990 Dec; 7(12):1222-7. PubMed ID: 1982773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.